BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 36358568)

  • 1. Targeting Ferroptosis as a Promising Therapeutic Strategy for Ischemia-Reperfusion Injury.
    Pan Y; Wang X; Liu X; Shen L; Chen Q; Shu Q
    Antioxidants (Basel); 2022 Nov; 11(11):. PubMed ID: 36358568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis: A Novel Therapeutic Target for Ischemia-Reperfusion Injury.
    Chen Y; Fan H; Wang S; Tang G; Zhai C; Shen L
    Front Cell Dev Biol; 2021; 9():688605. PubMed ID: 34447746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Ferroptosis to Treat Cardiovascular Diseases: A New Continent to Be Explored.
    Huang F; Yang R; Xiao Z; Xie Y; Lin X; Zhu P; Zhou P; Lu J; Zheng S
    Front Cell Dev Biol; 2021; 9():737971. PubMed ID: 34527678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Role of Ferroptosis in the Pathogenesis of Ischemic Stroke: A New Therapeutic Target?
    Bu ZQ; Yu HY; Wang J; He X; Cui YR; Feng JC; Feng J
    ASN Neuro; 2021; 13():17590914211037505. PubMed ID: 34463559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis-A New Dawn in the Treatment of Organ Ischemia-Reperfusion Injury.
    Zhou L; Han S; Guo J; Qiu T; Zhou J; Shen L
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Caryophyllene suppresses ferroptosis induced by cerebral ischemia reperfusion via activation of the NRF2/HO-1 signaling pathway in MCAO/R rats.
    Hu Q; Zuo T; Deng L; Chen S; Yu W; Liu S; Liu J; Wang X; Fan X; Dong Z
    Phytomedicine; 2022 Jul; 102():154112. PubMed ID: 35550220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting ferroptosis: a novel insight against myocardial infarction and ischemia-reperfusion injuries.
    Han X; Zhang J; Liu J; Wang H; Du F; Zeng X; Guo C
    Apoptosis; 2023 Feb; 28(1-2):108-123. PubMed ID: 36474078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting ferroptosis in ischemia/reperfusion renal injury.
    Thapa K; Singh TG; Kaur A
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Nov; 395(11):1331-1341. PubMed ID: 35920897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Ferroptosis: Pathological Mechanism and Treatment of Ischemia-Reperfusion Injury.
    Li X; Ma N; Xu J; Zhang Y; Yang P; Su X; Xing Y; An N; Yang F; Zhang G; Zhang L; Xing Y
    Oxid Med Cell Longev; 2021; 2021():1587922. PubMed ID: 34745412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathological role of ferroptosis in ischemia/reperfusion-related injury.
    Yan HF; Tuo QZ; Yin QZ; Lei P
    Zool Res; 2020 May; 41(3):220-230. PubMed ID: 32314558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular mechanisms and potential drug targets of ferroptosis in myocardial ischemia-reperfusion injury.
    Zhang CH; Yan YJ; Luo Q
    Life Sci; 2024 Mar; 340():122439. PubMed ID: 38278348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron Overload via Heme Degradation in the Endoplasmic Reticulum Triggers Ferroptosis in Myocardial Ischemia-Reperfusion Injury.
    Miyamoto HD; Ikeda M; Ide T; Tadokoro T; Furusawa S; Abe K; Ishimaru K; Enzan N; Sada M; Yamamoto T; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
    JACC Basic Transl Sci; 2022 Aug; 7(8):800-819. PubMed ID: 36061338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broadening horizons: The role of ferroptosis in myocardial ischemia-reperfusion injury.
    Zhao K; Chen X; Bian Y; Zhou Z; Wei X; Zhang J
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2269-2286. PubMed ID: 37119287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Insight Into the Fate of Cardiomyocytes in Ischemia-Reperfusion Injury: From Iron Metabolism to Ferroptosis.
    Li JY; Liu SQ; Yao RQ; Tian YP; Yao YM
    Front Cell Dev Biol; 2021; 9():799499. PubMed ID: 34926476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCTR1 inhibits ferroptosis by promoting NRF2 expression to attenuate hepatic ischemia-reperfusion injury.
    Ye J; Peng J; Liu K; Zhang T; Huang W
    Am J Physiol Gastrointest Liver Physiol; 2022 Sep; 323(3):G283-G293. PubMed ID: 35916424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferroptosis in organ ischemia-reperfusion injuries: recent advancements and strategies.
    Luan X; Chen P; Miao L; Yuan X; Yu C; Di G
    Mol Cell Biochem; 2024 Mar; ():. PubMed ID: 38556592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion.
    Li Y; Feng D; Wang Z; Zhao Y; Sun R; Tian D; Liu D; Zhang F; Ning S; Yao J; Tian X
    Cell Death Differ; 2019 Nov; 26(11):2284-2299. PubMed ID: 30737476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferroptosis as a novel therapeutic target for cardiovascular disease.
    Wu X; Li Y; Zhang S; Zhou X
    Theranostics; 2021; 11(7):3052-3059. PubMed ID: 33537073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron Metabolism in Ferroptosis.
    Chen X; Yu C; Kang R; Tang D
    Front Cell Dev Biol; 2020; 8():590226. PubMed ID: 33117818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative Stress and Ischemia/Reperfusion Injury in Kidney Transplantation: Focus on Ferroptosis, Mitophagy and New Antioxidants.
    Granata S; Votrico V; Spadaccino F; Catalano V; Netti GS; Ranieri E; Stallone G; Zaza G
    Antioxidants (Basel); 2022 Apr; 11(4):. PubMed ID: 35453454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.